Drug Type Small molecule drug |
Synonyms MGL 3745, MGL-3745 |
Target |
Mechanism THR-β agonists(Thyroid hormone receptor beta-1 agonists) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hyperlipidemia Type IIa | Preclinical | US | - | |
MASH | Preclinical | US | - |